Heart failure
Heart failure, also known as "myocardial failure", refers to the inability of the heart to pump out blood in proportion to the venous return and body tissue metabolism. It is often caused by various diseases that weaken the myocardial contractility, thereby reducing the heart's blood output, which is insufficient to meet the body's needs, and thus produces a series of symptoms and signs.
-
Site of disease:
heart -
Infectious :
Not contagious -
Frequent population:
All populations, mostly middle-aged and elderly people -
Related symptoms:
Difficulty breathing Orthopnea Cough Pink foamy sputum Dizziness -
Concurrent disease:
Related Drugs
Sodium Fructose Diphosphate Injection
Indication: It is suitable for improving angina pectoris of coronary heart disease, acute myocardial infarction and arrhythmia, and myocardial ischemia of heart failure.
Sodium Fructose Diphosphate Injection
Indication: It is suitable for improving angina pectoris of coronary heart disease, acute myocardial infarction and arrhythmia, and myocardial ischemia of heart failure.
Amiodarone Hydrochloride Tablets
Indication: It is clinically applicable to ventricular and supraventricular tachycardia and premature beats, paroxysmal atrial flutter and fibrillation, preexcitation syndrome, etc. It can also be used for patients with arrhythmias accompanied by congestive heart failure and acute myocardial infarction. It can also be effective for refractory paroxysmal tachycardia that is ineffective with other β-receptor blockers. In addition, it is also used to treat chronic coronary artery insufficiency and angina pectoris.
Manufacturer:
Sanofi (Hangzhou) Pharmaceuticals Co., Ltd.
Nifedipine
Indication: Clinically applicable to the prevention and treatment of angina pectoris caused by coronary heart disease, especially variant angina pectoris and angina pectoris caused by coronary artery spasm. Applicable to various types of hypertension, and also has good efficacy on refractory and severe hypertension. Raynaud's syndrome. Because it can reduce afterload, it also has good efficacy on refractory congestive heart failure and is suitable for long-term use. In addition, it is also suitable for patients with angina pectoris suffering from obstructive respiratory diseases, and its efficacy is better than beta-receptor blockers.
Manufacturer:
Jiaozuo Furuitang Pharmaceutical Co., Ltd.
Nifedipine
Indication: Clinically applicable to the prevention and treatment of angina pectoris caused by coronary heart disease, especially variant angina pectoris and angina pectoris caused by coronary artery spasm. Applicable to various types of hypertension, and also has good efficacy on refractory and severe hypertension. Raynaud's syndrome. Because it can reduce afterload, it also has good efficacy on refractory congestive heart failure and is suitable for long-term use. In addition, it is also suitable for patients with angina pectoris suffering from obstructive respiratory diseases, and its efficacy is better than beta-receptor blockers.
Manufacturer:
Yantai Luyin Pharmaceutical Co., Ltd.
Nifedipine
Indication: Clinically applicable to the prevention and treatment of angina pectoris caused by coronary heart disease, especially variant angina pectoris and angina pectoris caused by coronary artery spasm. Applicable to various types of hypertension, and also has good efficacy on refractory and severe hypertension. Raynaud's syndrome. Because it can reduce afterload, it also has good efficacy on refractory congestive heart failure and is suitable for long-term use. In addition, it is also suitable for patients with angina pectoris suffering from obstructive respiratory diseases, and its efficacy is better than beta-receptor blockers.
Manufacturer:
Shaanxi XIYUE Pharmaceutical Co., Ltd.
Sodium fructose diphosphate
Indication: It is suitable for improving angina pectoris, acute myocardial infarction and arrhythmia caused by coronary heart disease, and myocardial ischemia caused by heart failure.
Manufacturer:
Shanghai SPH New ASIA Pharmaceutical Co., Ltd.
Sodium fructose diphosphate
Indication: It is suitable for improving angina pectoris, acute myocardial infarction and arrhythmia caused by coronary heart disease, and myocardial ischemia caused by heart failure.
Manufacturer:
Shanghai SPH New ASIA Pharmaceutical Co., Ltd.
Sodium fructose diphosphate
Indication: It is suitable for improving angina pectoris, acute myocardial infarction and arrhythmia caused by coronary heart disease, and myocardial ischemia caused by heart failure.
Manufacturer:
Shanghai SPH New ASIA Pharmaceutical Co., Ltd.
Nitroglycerin solution
Indication: It is used for the treatment and prevention of angina pectoris caused by coronary heart disease, and can also be used to lower blood pressure or treat congestive heart failure.
Manufacturer:
Beijing Yimin Pharmaceutical Co., Ltd.